Burzynski Research Institute, Inc. (BZYR)
OTCMKTS · Delayed Price · Currency is USD
0.0045
-0.0015 (-25.00%)
Jul 28, 2026, 3:29 PM EST
BZYR Market Cap
BZYR has a market cap or net worth of $687.61 thousand as of July 30, 2026. Its market cap has decreased by -89.10% in one year.
Market Cap
687.61K
Enterprise Value
685.44K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since April 28, 1997, BZYR's market cap has decreased from 16.41M to 687.61K, a decrease of -95.81%. That is a compound annual growth rate of -10.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 687.61K | -72.61% |
| Dec 29, 2025 | 2.51M | -38.39% |
| Dec 31, 2024 | 4.07M | -29.55% |
| Dec 29, 2023 | 5.78M | 70.28% |
| Dec 23, 2022 | 3.40M | 115.33% |
| Dec 31, 2021 | 1.58M | -33.33% |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regenerative Medical Technology Group | 1.11M |
| Nymox Pharmaceutical | 1.06M |
| Evofem Biosciences | 1.05M |
| Avenue Therapeutics | 944.73K |
| ZyVersa Therapeutics | 939.13K |
| Lyra Therapeutics | 887.44K |
| Emmaus Life Sciences | 823.31K |
| Agentix | 801.34K |